Biotricity Launches Extensive Cardiac Monitoring Pilot Program Across 9 Hospitals and 10 Clinics

Biotricity Inc., a Technology-as-a-Service leader in medical diagnostics and consumer healthcare, has initiated an extensive cardiac monitoring pilot program with a major hospital group. This network includes 9 hospitals and 10 clinics. The program is designed to enhance patient interactions and streamline data assessments, demonstrating the potential of Biotricity's advanced technology suite.

The move follows Biotricity's recent establishment of partnerships with significant Group Purchasing Organizations (GPOs), influencing an expansive range of $264 billion. These partnerships have extended Biotricity's technology reach to 90% of hospitals nationwide, facilitating broader access to advanced medical care. Dr. Waqaas Al-Siddiq, CEO, emphasized the pilot's role in advancing disease profiling and healthcare methodologies.

Positioning themselves within a $35 billion market, Biotricity aims to significantly influence future healthcare landscapes through innovative technological solutions. For more detailed insights into the company's projections and technologies, visit their investor relations website.